Legal

Last Updated: May 2025

BATWATCH™ uses a proprietary language system designed to improve communication, reduce stigma, and promote early action in brain health. These terms are part of a legally protected, trademarked framework that simplifies biological complexity into clear, actionable language for patients, providers, and stakeholders.

This document establishes the definitional scope, protected use, and discovery limitations of all BAT™ terms. It is not intended for commercialization but to protect the intellectual integrity of the system.

1. Purpose of Unified Terminology

Traditional brain health language often feels clinical, overwhelming, or too late to be useful. The BATWATCH™ framework reframes this entirely by:

Replacing fear-based language with hopeful, prevention-first terms.

Creating a consistent structure for interpreting biomarkers across care teams.

Empowering patients to act early, with clarity rather than confusion.

Reducing variability in clinical conversations by standardizing communication.

These terms are not generic descriptors, but proprietary labels used within a systematized framework that integrates:

Biomarker testing and stratification

Off-label intervention tracking

Longitudinal registry analysis

Educational and challenge-based engagement

2. Trademarked Terminology Overview

All terms listed below are protected under U.S. and international trademark laws and are the subject of ongoing enforcement and registry maintenance. Use without license or attribution is prohibited.

BATWATCH™

Definition: A nationwide system to monitor biological drift, track BAT LEVELS™, and implement early action protocols for brain health.
Protected Use: Platform identity, registry infrastructure, and integrated provider workflows.
Not a generic term for: brain screening platforms or registry models.

BATWATCH™ Protocol

Definition: The operational framework linking biomarker testing, risk stratification, and short-cycle intervention (where appropriate).
Protected Use: Refers to the entire integrated care model, not individual services.

BAT LEVELS™

Definition: Quantified Beta-Amyloid and Tau measurements used as early biological indicators.
Protected Use: Only applies within the BATWATCH™ interpretation model.
Note: Not a synonym for “biomarkers” or “plasma Aβ levels” outside the program context.

BAT SCORE™

Definition: A simplified summary of current BAT LEVELS™, visualized on an intuitive scale.
Protected Use: Consumer-facing summary metric designed for rapid interpretation.
Proprietary Element: Scaling method and risk thresholds are proprietary and trade secret.

BAT LEVEL INDEX™ (BLI)

Definition: A three-stage risk scoring system derived from testing, history, and response tracking.
Protected Use: May not be replicated, reverse-engineered, or republished.
Trade Secret Warning: Algorithm and scoring logic are proprietary, non-public, and discovery-exempt under state and federal trade secret law.

BAT CHECK™

Definition: A single-point lab test used as a challenge entry into the BATWATCH™ system.
Protected Use: Refers only to BATWATCH™ entry-point testing workflows.
Not a synonym for: general brain screenings or unrelated biomarker tests.

BAT TEST™

Definition: An umbrella term for validated, blood-based quantification of Aβ and Tau markers that meet internal lab standards.
Protected Use: Describes BATWATCH™-approved testing sources, not any lab offering Aβ/Tau testing.

BAT TESTING™

Definition: The longitudinal, lab-agnostic process of capturing, tracking, and interpreting BAT LEVELS™.
Protected Use: Includes registry data ingestion, not simply ordering a test.

BAT PILL™

Definition: A short-cycle, off-label therapeutic strategy leveraging autophagy-activating medications to reduce BAT LEVELS™.
Protected Use: The term applies only when used under the BAT PILL™ Protocol.
Trademark Notice: Misuse or use in connection with non-protocol drugs or unsanctioned programs is strictly prohibited.

BAT PILL™ Protocol

Definition: The formal care pathway outlining eligibility, dosing, clearance, and re-assessment related to BAT PILL™ cycles.
Proprietary Notice: Components include dosing intervals, re-challenge strategies, and biomarker re-testing triggers.

BATOPHAGY™

Definition: A branded term referring to the autophagic clearance of Beta-Amyloid and Tau.
Use Case: For educational and metaphorical use only; not a literal medical claim.
Scientific Basis: Describes cellular-level processes supported by internal and external research, but phrased in accessible public language.

BAT LEVELS™ Awareness Month

Definition: A national engagement campaign focused on early detection and empowerment.
Protected Use: Includes branded events, influencer content, and challenge-based testing incentives.

BATWATCH™ Registry

Definition: The national, longitudinal database capturing biomarker trends and protocol outcomes across patients.
Protected Use: Encompasses both anonymized research data and registry-linked clinical interactions.
Data Security Warning: All internal datasets are protected as confidential and proprietary assets.

BATWATCH™ (Media Platform)

Definition: A branded series of videos, public experiments, and challenge-based events aimed at public education.
Protected Use: Covers the “MrBrainHealth” branded content ecosystem.
Trademark Scope: Includes audiovisual format, challenge brand assets, and associated character IP.

3. Use, Access, and Enforcement

a) Internal Use Only:
These terms are provided for clarity within the BATWATCH™ Program. They are not licensed for use outside authorized materials or partnerships.

b) Third-Party Prohibition:
No third party may use these terms in connection with any brain-related testing, analysis, intervention, software product, or consumer education campaign without explicit written permission.

c) Discovery Protection:
The definitions, usage rules, scaling systems, and underlying logic of BAT terminology are protected under trade secret law. They may not be requested, subpoenaed, or extracted through discovery without a showing of direct medical necessity and court-approved protective order. All rights are reserved.

d) Enforcement Rights Reserved:
BATWATCH™ will pursue legal remedies in cases of misuse, misrepresentation, confusion, dilution, or replication of these terms or associated program components.

e) No Implied Licensing:
Listing these terms on a website or in educational content does not constitute a public license or fair use grant. Each is protected under trademark law and may not be adopted into derivative works, grant applications, or clinical programs.